Nature Medicine
- 12, 1237 - 1238 (2006)
doi:10.1038/nm1106-1237
Stem cells: the good, bad and barely in controlChristian T Carson, Stefan Aigner & Fred H Gage
The authors are at the Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, USA. gage@salk.edu
kanjiThe goal of replacing dying cells in Parkinson disease with stem cells is now brought a step closer to the clinic. A new protocol eases symptoms in a rat model of the disease, but also raises the concern that poorly differentiated cells have the potential to become tumorigenic (pages 1259–1268).
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
